(Q41815393)

12 October 2017

Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin (English)

1 reference

12 October 2017

temporal lobe epilepsy

1 reference

Hardus P

1

1 reference

12 October 2017

Verduin WM

2

1 reference

12 October 2017

Postma G

3

1 reference

12 October 2017

Stilma JS

4

1 reference

12 October 2017

Berendschot TT

5

1 reference

12 October 2017

van Veelen CW

6

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

British Journal of Ophthalmology

12 October 2017

1 reference

12 October 2017

84

1 reference

12 October 2017

7

1 reference

12 October 2017

788-790

1 reference

Characteristics of a unique visual field defect attributed to vigabatrin

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Visual field defects associated with vigabatrin therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Study is needed of visual field defects associated with any long term antiepileptic drug

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Severe persistent visual field constriction associated with vigabatrin

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Measuring performance in the NHS.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Automated perimetry and malingerers. Can the Humphrey be outwitted?

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723565

Field of dreamers and dreamed-up fields: functional and fake perimetry

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10873996

12 December 2020

inferred from PubMed ID database lookup

Reversibility of vigabratin-induced visual-field defect

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10873996

12 December 2020

inferred from PubMed ID database lookup

[Examination strategies in simulation and functional vision disorders]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10873996

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BJO.84.7.788

1 reference

release_jav5aa3in5gy3hyx3rrocywmay

12 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jav5aa3in5gy3hyx3rrocywmay

24 November 2022

mapped directly with Wikidata item

1 reference

12 October 2017

PubMed publication ID

10873996

1 reference